DIAGNOS
-
Andre Larente from DIAGNOS to Host InvestorTalk (04.24.2024)
InvestorNews is hosting an InvestorTalk this morning with André Larente, CEO, President, and Director from DIAGNOS Inc. (TSXV:…
-
Andre Larente from DIAGNOS on Deal with World’s Largest Eyecare Retailer EssilorLuxottica
InvestorNews host Tracy Weslosky recently conducted an insightful interview with André Larente, President and Director of DIAGNOS Inc.…
-
Investor.Coffee (12.11.2023): CDN Healthcare Deal, U.S. Dollar Gains Strength on Japan’s Nikkei Rebound
DIAGNOS Inc. (TSXV: ADK | OTCQB: DGNOF), a company we have followed for several years out of Montreal, announced…
-
Applying AI for the good of humanity, a tool for early detection of preventable blindness in diabetes patients is here
Is Artificial Intelligence (AI) going to save the world? Likely not if you are a fan of the…
-
The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease
Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage…
-
André Larente provides an update on the ‘exponential growth’ of the Diagnos AI-based telemedicine platform
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente, President of Diagnos Inc. (TSXV: ADK |…
-
Eyes on DIAGNOS as commercialization gains momentum
The best time to buy an emerging company is when it begins commercialization. At this stage all the…
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
-
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology
CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is…
-
Thompson on DIAGNOS and the ‘exploding’ AI healthtech industry
AI Healthcare Provider Diagnos Continues to Sign Deals and Partnerships Amid COVID-19 Crisis Diagnos Inc. (TSXV: ADK |…